Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics

Journal of Receptor and Signal Transduction Research

Volumn 19, Issue 1-4, 1999, Pages 573-588

  Schiller, P W ^a   Weltrowska, G ^a   Schmidt, R ^a   Berezowska, I ^a   Nguyen, T M D ^a   Lemieux, C ^a   Chung, N N ^a   Carpenter, K A ^a   Wilkes, B C ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINALTORPHIMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DYNORPHIN A DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; LEUCINE ENKEPHALIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALTREXONE; NALTRINDOLE; NORBINALTORPHIMINE; OCTREOTIDE; TYROSYL (1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXYLATE)PHENYLALANYLPHENYLALANINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANALGESIA; BINDING KINETICS; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG CONFORMATION; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG SYNTHESIS; HUMAN; MOLECULAR MODEL; MORPHINE TOLERANCE; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR AFFINITY;

EID: 0033035125     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899909036673     Document Type: Conference Paper

References (33)

1. Shaw, J.S.; Miller, L.; Turnbull, M.J.; Gormley, J.J. and Morley, J.S. Selective antagonists at the opiate delta receptor. Life Sci. 31, 1259-1262, 1982.
2. Corbett, A.D.; Gillan, M.G.C.; Kosterlitz, H.W.; McKnight, A.T.; Paterson, S.J. and Robson, L.E. Selectivities of opioid peptide analogues as agonists and antagonists at the δ-receptor. Br. J. Pharmacol. 83, 271-279, 1984.
3. Schiller, P.W.; Nguyen, T.M.-D.; Weltrowska, G.; Wilkes, B.C.; Marsden, B.J.; Lemieux, C. and Chung, N.N. Differential stereochemical requirements of μ versus δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists. Proc. Natl. Acad. Sci. USA. 89, 11871-11875, 1992.
4. Schiller, P.W.; Weltrowska, G.; Wilkes, B.C.; Chung, N.N. and Lemieux, C. TEPP[Ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 36, 3182-3187, 1993.
5. Portoghese, P.S.; Sultana, M.; Nagase, H. and Takemori, A.E. Application of the message-address concept in the design of highly potent and selective non-peptide δ opioid receptor antagonists. J. Med. Chem. 31, 281-282, 1988.
6. Maurer, R.; Gaehwiler, B.H.; Buescher, H.H.; Hill, R.C. and Roemer, D. Opiate antagonistic properties of an octapeptide somatostatin analog. Proc. Natl. Acad. Sci. USA. 79, 4815-4817, 1982.
7. Kazmierski, W.; Wire, W.S., Lui, G.K.; Knapp, R.J.; Shook, J.E.; Burks, T.F.; Yamamura, H.I. and Hruby, V.J. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific μ opioid receptor antagonists with greatly reduced binding at somatostatin receptors. J. Med. Chem. 31, 2170-2711, 1988.
8. 10]dynorphin A-(1-11). Br. J. Pharmacol. 95, 1023-1030, 1980.
9. Portoghese, P.S.; Lipkowski, A.W. and Takemori, A.E. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life. Sci. 40, 1287-1292, 1987.
10. Marsden, B.J.; Nguyen, T.M.-D. and Schiller, P.W. Spontaneous degradation via diketopiperazine formation of peptides containing a tetrahydroisoquinoline-3-carboxylic acid residue in the 2-position of the peptide sequence. Int. J. Peptide Protein Res. 41, 313-316, 1993.
11. Schiller, P.W.; Weltrowska, G.; Nguyen, T.M.-D.; Lemieux, C.; Chung, N.N.; Zelent, B.; Wilkes, B.C. and Carpenter, K.A. Structure-agonist/antagonist relationships of TIPP analogs. In Peptides: Chemistry, Structure and Biology (Proc. 14th Amer. Peptide Symp.), p. 609-611, edited by P.T.P. Kaumaya and R.S. Hodges, Mayflower Scientific Ltd., Kingswinford, England, 1996.
12. Schiller, P.W.; Nguyen, T.M.-D.; Weltrowska, G.; Wilkes, B.C.; Marsden, B.J.; Schmidt, R.; Lemieux, C. and Chung, N.N. TIPP opioid peptides: development of extraordinarily potent and selective δ antagonists and observation of astonishing structure-intrinsic activity relationships. In Peptides: Chemistry, Structure and Biology (Proc. 13th Amer. Peptide Symp.), p. 483-486, edited R.S. Hodges and J.A. Smith, ESCOM Science Publishers, Leiden, The Netherlands, 1994.
13. Salvadori, S.; Attila, M.; Balboni, G; Bianchi, C.; Bryant, S.C.; Crescenzi, O.; Guerrini, R.; Picone, D. and Tandredi, T. δ Opioid mimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides Mol. Med. 1, 678-689, 1995.
14. Schiller, P.W.; Schmidt, R.; Weltrowska, G.; Berezowska, I.; Nguyen, T.M.-D.; Dupuis, S.; Chung, N.N.; Lemieux, C.; Wilkes, B.C. and Carpenter, K. A. Conformationally constrained opioid peptide analogs with novel activity profiles. Lett. Peptide Sci. 5, 209-214, 1998.
15. 2. Biopolymers 34, 1213-1219, 1994.
16. Wilkes, B.C. and Schiller, P.W. Comparative analysis of several proposed models of the receptor-bound conformation of TIP(P)-related δ opioid antagonists. Biopolymers (Peptide Science) 37, 391-400, 1995.
17. Temussi, P.A.; Salvadori, S.; Amadeo, P.; Bianchi, C.; Guerrini, R.; Tomatis, R.; Lazarus, L.H.; Picone, D. and Tancredi, T. Selective opioid dipeptides. Biochem. Biophys. Res. Commun. 198, 933-939, 1994.
18. Wilkes, B.C.; Nguyen, T.M.-D.; Weltrowska, G.; Carpenter, K.A.; Lemieux, C.; Chung, N.N. and Schiller, P.W. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related δ-opioid antagonists contains all trans peptide bonds. J. Peptide Res. 51, 386-394, 1998.
19. 3H]TIPP. Life Sci. (Pharmacol. Lett.) 53, PL 57-62, 1993.
20. Nevin, S.T.; Toth, G.; Weltrowska, G.; Schiller, P.W. and Borsodi, A. Synthesis and binding characteristics of tritiated TIPP[Ψ], a highly specific and stable delta opioid antagonist. Life Sci. (Pharmacol. Lett.) 56, PL 225-230, 1995.
21. Visconti, L.M.; Standifer, K.M.; Schiller, P.W. and Pasternak, G.W. TIPP[Ψ], a highly selective delta opioid ligand. Neurosci. Lett. 181, 47-49, 1994.
22. Abdelhamid, E.E.; Sultana, M.; Portoghese, P.S. and Takemori, A.E. Selective blockage of δ opioid reeptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258, 299-303, 1991.
23. 2-NH]Phe-Phe-OH (TIPP[Ψ]) attenuates morphine tolerance and dependence. Eur. J. Pharmacol. 286, 105-108 (1995).
24. Schiller, P.W.; Weltrowska, G.; Schmidt, R.; Nguyen, T.M.-D.; Berezowska, I.; Lemieux, C.; Chung, N.N.; Carpenter, K.A. and Wilkes, B.C. Four different types of opioid peptides with mixed μ agonist/δ antagonist properties. Analgesia 1, 703-706, 1995.
25. Lee, P.H.K.; Nguyen, T.M.-D.; Chung, N.N.; Schiller, P.W. and Chang, K.-J. Tyrosine-iodination converts the delta opioid peptide antagonist TIPP to an agonist. Eur. J. Pharmacol. 280, 211-214, 1995.
26. Schiller, P.W.; Weltrowska, G.; Nguyen, T.M.-D.; Lemieux, C. and Chung, N.N. Novel opioid peptide analogs with mixed μ agonist/δ antagonist properties. In Peptides 1994 (Proc. 23rd Eur. Peptide Symp.), p. 632-633, edited by H.L.S. Maia, ESCOM Science Publishers, Leiden, the Netherlands, 1995.
27. Schiller, P.W.; Weltrowska, G.; Bolewska-Pedyczak, E.; Nguyen, T.M.-D.; Lemieux, C. and Chung, N.N. Subtleties of structure - δ agonist vs. δ antagonist relationships of opioid dipeptide derivatives. In Peptides 1996 (Proc. 24th Eur. Peptide Symp.), edited by R. Ramage and R. Epton, Mayflower Scientific Ltd., Kingswinford, England, in press.
28. Lomize, A.L.; Pogozheva, I.D. and Mosberg, H.I. Development of a model for the δ-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained δ-receptor selective ligands. Biopolymers 38, 221-234, 1996.
29. Schiller, P.W.; Weltrowska G.; Berezowska, I.; Lemieux, C.; Chung, N.N.; Carpenter, K.A. and Wilkes, B.C. A new class of dipeptide derivatives that are potent and selective δ opioid agonists. In Peptides: Chemistry, Structure and Biology (Proc. 15th Amer. Peptide Symp.), edited by J.P. Tam and P.T.P. Kaumaya, Kluwer Academic Publishers, Dordrecht, The Netherlands, in press.
30. Morton, A. and Matthews, B.C. Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity. Biochemistry 34, 8576-8588, 1995.
31. Tuček, S. Is the R and R* dichotomy real? Trends Pharmacol. Sci. 18, 414-416, 1997.
32. Kenakin, S. Agonist-specific receptor conformations. Trends Pharmacol. Sci. 18, 416-417, 1997.
33. Claude, P.A.; Wotta, D.R.; Zhang, X.H.; Prather, P.L.; McGinn, T.M.; Erickson, L.J.; Loh, H.H. and Law, P. Y. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc. Natl. Acad. Sci. USA 93, 5715-5719, 1996.